Skip to Content

Drug Interactions between Okebo and sucroferric oxyhydroxide

This report displays the potential drug interactions for the following 2 drugs:

  • Okebo (doxycycline)
  • sucroferric oxyhydroxide

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

doxycycline sucroferric oxyhydroxide

Applies to: Okebo (doxycycline) and sucroferric oxyhydroxide

Sucroferric oxyhydroxide and doxycycline should not be taken orally at the same time. Products that contain iron such as sucroferric oxyhydroxide may interfere with the absorption of doxycycline and reduce its effectiveness. To prevent or minimize the interaction, you should take doxycycline at least one to four hours before sucroferric oxyhydroxide. Talk to your doctor or pharmacist if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.